Advances in targeted therapy and immunotherapy for melanoma (Review)

Ziyao Qin1, Mei Zheng1

  • 1No. 4 Research Laboratory, Shanghai Institute of Biological Products Co., Ltd., Shanghai 200051, P.R. China.

Insights

New targeted therapies and immunotherapies have emerged for metastatic melanoma. This review examines clinical trials of these treatments and their combinations to improve outcomes for advanced skin cancer.

Area of Science:

  • Oncology
  • Dermatology
  • Cancer Research

Background:

  • Melanoma is an aggressive skin cancer with a poor prognosis upon metastasis.
  • Recent advancements include FDA-approved targeted agents (BRAF/MEK inhibitors) and immunotherapies (CTLA-4, PD-1/PD-L1 blockade).

Purpose of the Study:

  • To review clinical trials of targeted therapy and immunotherapy for metastatic melanoma.
  • To explore novel combination approaches and upcoming strategies to enhance treatment efficacy.

Main Methods:

  • Review of recent clinical trials and literature on metastatic melanoma treatments.
  • Analysis of targeted therapy, immunotherapy, and combination strategies.

Main Results:

  • Significant progress in metastatic melanoma treatment since 2011 with new targeted and immune agents.
  • Emerging data on the efficacy of combining targeted therapy and immunotherapy.

Conclusions:

  • Combination therapies hold promise for improving outcomes in metastatic melanoma.
  • Ongoing research focuses on optimizing these treatments for better patient survival.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...